Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06505018
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-10
Brief Title:
Telemonitoring Platform CUREETY TECHCARE vs Standard of Care for mTBNC Patients Initiating a First-line Treatment
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Phase III Study Comparing the Digital Telemonitoring Platform CUREETY TECHCARE to Usual Standard of Care in Patients With Triple Negative Metastatic Breast Cancer Initiating a First-line Systemic Treatment
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ALTERNATIVE
Brief Summary:
The goal of this clinical trial is to assess whether adding telemonitoring the digital telemonitoring platform CUREETY TECHCARE to standard care will benefit patients with previously untreated metastatic triple-negative breast cancer starting first-line cancer therapy
The main questions it aims to answer are
Is patient quality of life improved by using the telemonitoring platform
Are patients hospitalized less frequently when using the telemonitoring platform
Is the patient overall survival improved by telemonitoring
Researchers will compare data from patients using telemonitoring while receiving standard care with data from patients receiving only standard care
Participants using telemonitoring will answer questions about their symptoms on the platform The platform will analyze these symptoms assess the patients general condition and provide advice accordingly Medical staff will also access the platform to monitor the patients general condition and contact them if necessary
The main questions it aims to answer are
Is patient quality of life improved by using the telemonitoring platform
Are patients hospitalized less frequently when using the telemonitoring platform
Is the patient overall survival improved by telemonitoring
Researchers will compare data from patients using telemonitoring while receiving standard care with data from patients receiving only standard care
Participants using telemonitoring will answer questions about their symptoms on the platform The platform will analyze these symptoms assess the patients general condition and provide advice accordingly Medical staff will also access the platform to monitor the patients general condition and contact them if necessary
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None